PATENT CLAIM ANALYSIS

Application Number: 16116117
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-06
Patent Classification: ["530", "300000"]

Abstract:
A novel peptide sequence that is a modified derivative of a neuron-specific tyrosine phosphatase is shown and described. Specifically, the novel peptide sequence is a modified derivative of striatal-enriched tyrosine phosphatase (STEP). The peptide sequence has been modified so as to be able to ameliorate and treat brain injury resulting from excessive glutamate release and/or oxidative stress. Examples of the types of brain injury which the presently disclosed peptide sequence is useful for treating includes acute brain injury resulting from stroke or traumatic brain injury and chronic disorders such as Huntington's chorea and schizophrenia. Furthermore, the presently described peptide sequence may further be useful in the treatment and amelioration of disorders associated with fear memory such as post-traumatic stress disorder.

Claim (Index 13):
The isolated peptide of  claim 6 , wherein the threonine residue of the KIS domain is replaced with an aspartic acid or a glutamic acid.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 96.0
- Lexical Diversity: 1.71053
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13823856', '14721024', '12392988', '14971432', '10930192']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6630283972425757
- 35 USC 102 Novelty (BERT): 0.6085878296888463
- Combined Prediction Score: 0.6575843404872027
- Mean Citation Score: 344.757602
- Max Citation Score: 515.5135
- Similarity Product: 502.6583683177829

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test